Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 6Phase 2 4Phase 1 3Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 12CNS 4Plasma cell 1Head & Neck 1

Conditions

Brain Neoplasms 3Recurrence 1Glioblastoma 1Disease 1

Interventions

Temozolomide 258Radiotherapy 147Bevacizumab 142Etoposide 68Cyclophosphamide 68Carboplatin 66Magnetic Resonance Spectroscopy 58Irinotecan 53Cisplatin 52Vincristine 45Filgrastim 43pembrolizumab 40Radiosurgery 36Nivolumab 36Radiation 34Topotecan 31Doxorubicin 30Specimen Handling 29sargramostim 28Lomustine 27Erlotinib Hydrochloride 27Peripheral Blood Stem Cell Transplantation 25Carmustine 25Thiotepa 24Everolimus 23Chemotherapy, Adjuvant 23Surgical Procedures, Operative 22Isotretinoin 22Ipilimumab 22Melphalan 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × fluciclovine F-18 × CNS × Clear all
NCT06319027 2026-05-15

GABLE

Eastern Cooperative Oncology Group

Phase 2 Recruiting
100 enrolled
CNS

Glioblastoma

NCT05554302 2025-12-01

CONCORDANT

Baptist Health South Florida

Phase 2 Recruiting
20 enrolled
CNS

Brain Neoplasms

NCT04410367 2025-07-20

PURSUE

Blue Earth Diagnostics

Phase 2 Completed
23 enrolled 10 charts
CNS

Brain Neoplasms, Disease

NCT03925675 2024-09-03

18F-Fluciclovine PET and Multiparametric MR Imaging

Loma Linda University

Phase 2 Withdrawn
CNS

Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡